Giorgio Zavagno

Summary

Affiliation: University of Padova
Country: Italy

Publications

  1. ncbi Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128, Padova, Italy
    Breast 16:146-51. 2007
  2. pmc Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    BMC Cancer 5:28. 2005
  3. doi A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Italy
    Ann Surg 247:207-13. 2008
  4. ncbi Clinical impact of false-negative sentinel lymph nodes in breast cancer
    G Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 34:620-5. 2008
  5. pmc Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region
    Giorgio Zavagno
    University of Padova, Istituto di Clinica Chirurgica II, Padova 35128, Italy
    BMC Cancer 4:2. 2004
  6. doi Role of resection margins in patients treated with breast conservation surgery
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Padova, Italy
    Cancer 112:1923-31. 2008
  7. doi Separate cavity margins excision as a complement to conservative breast cancer surgery
    G Zavagno
    Clinica Chirurgica II Breast Unit, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 36:632-8. 2010
  8. ncbi Subareolar injection for sentinel lymph node location in breast cancer
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128, Padova, Italy
    Eur J Surg Oncol 28:701-4. 2002
  9. ncbi Sentinel lymph node biopsy in breast cancer: the GIVOM experience in Veneto, Italy
    G Zavagno
    Clinica Chirurgica II, Universita di Padova, Italy
    Tumori 88:S52-4. 2002
  10. ncbi Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients
    G Zavagno
    Istituto Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 31:715-20. 2005

Collaborators

Detail Information

Publications21

  1. ncbi Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128, Padova, Italy
    Breast 16:146-51. 2007
    ..In cases of SLN involvement, even if micrometastatic, our policy is to perform a complete ALND...
  2. pmc Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    BMC Cancer 5:28. 2005
    ..However, the indications for SLN biopsy in DCIS patients are controversial. The aim of the present study was therefore to assess the incidence of SLN metastases in a series of patients with a diagnosis of pure DCIS...
  3. doi A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Italy
    Ann Surg 247:207-13. 2008
    ..The aim of this multicenter randomized trial was to assess the efficacy and safety of sentinel lymph node (SLN) biopsy compared with axillary lymph node dissection (ALND)...
  4. ncbi Clinical impact of false-negative sentinel lymph nodes in breast cancer
    G Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 34:620-5. 2008
    ....
  5. pmc Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region
    Giorgio Zavagno
    University of Padova, Istituto di Clinica Chirurgica II, Padova 35128, Italy
    BMC Cancer 4:2. 2004
    ..The aim of the present survey was therefore to investigate the way in which SNB is used by general surgeons working in the Veneto region, Italy...
  6. doi Role of resection margins in patients treated with breast conservation surgery
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Padova, Italy
    Cancer 112:1923-31. 2008
    ..The aim of this study was to investigate how margin status and other clinicopathologic factors correlate with the presence of residual tumor at reexcision...
  7. doi Separate cavity margins excision as a complement to conservative breast cancer surgery
    G Zavagno
    Clinica Chirurgica II Breast Unit, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 36:632-8. 2010
    ..However, approximately half of these patients have no residual tumour in the re-excision specimen. The aim of this study was to investigate if separate cavity margin (CM) excision can safely reduce the need of re-operation...
  8. ncbi Subareolar injection for sentinel lymph node location in breast cancer
    Giorgio Zavagno
    Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128, Padova, Italy
    Eur J Surg Oncol 28:701-4. 2002
    ..In order to test this hypothesis, we ascertained whether subareolar blue dye injection and subdermal radioisotope injection close to the tumour identify the same axillary nodes...
  9. ncbi Sentinel lymph node biopsy in breast cancer: the GIVOM experience in Veneto, Italy
    G Zavagno
    Clinica Chirurgica II, Universita di Padova, Italy
    Tumori 88:S52-4. 2002
  10. ncbi Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients
    G Zavagno
    Istituto Clinica Chirurgica II, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Eur J Surg Oncol 31:715-20. 2005
    ....
  11. ncbi Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer
    Giorgio Zavagno
    Istituto di Clinica Chirurgica II, University of Padova, Italy
    Breast Cancer Res Treat 86:171-9. 2004
    ..The aim of this study was to investigate factors predictive of NSNs involvement, in order to identify patients with metastatic disease confined to the SN which might avoid ALND...
  12. ncbi Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma
    Simone Mocellin
    Clinica Chirurgica 2, Dipartimento di Scienze Oncologiche e Chirurgiche, Universita di Padova, Via Giustiniani, 2, 35128 Padova, Italy
    Ann Surg Oncol 13:1113-22. 2006
    ..In this study, the predictive power of support vector machine (SVM)-based statistical analysis was tested...
  13. doi Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis
    Pierluigi Pilati
    Surgery Branch, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy
    Ann Surg Oncol 19:402-8. 2012
    ..We tested the hypothesis that the detection of circulating tumor cells (CTC) might identify patients at high risk of dying of disease recurrence after apparently radical liver surgery...
  14. ncbi The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients
    Carlo Riccardo Rossi
    Department of Oncological and Surgical Sciences, Istituto di Clinica Chirurgica Generale II, Padova, Italy
    J Surg Oncol 83:80-4. 2003
    ..To evaluate the efficacy of preoperative ultrasound (US) scanning in identifying lymph node metastasis before sentinel node biopsy (SNB), we conducted a prospective study on 125 patients with primary cutaneous melanoma (CM)...
  15. doi The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis
    Simone Mocellin
    Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy
    Int J Cancer 123:2370-6. 2008
    ..Further investigation focusing on this subset of patients is justified and warranted before S100B can be implemented in the routine clinical management of melanoma...
  16. ncbi Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial
    P Del Bianco
    Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, Padova, Italy
    Eur J Surg Oncol 34:508-13. 2008
    ....
  17. ncbi Sentinel node biopsy and ultrasound scanning in cutaneous melanoma: clinical and technical considerations
    C R Rossi
    Dipartimento di Scienze Oncologiche e Chirurgiche, Sezione di Clinica Chirurgica II, Universita degli Studi di Padova, Via Giustiniani 2, 35128, Padova, Italy
    Eur J Cancer 36:895-900. 2000
    ..Breslow thickness and the number of metastatic SN(s), but not their type, are correlated with disease spread; CP10S contributed to the differentiation amongst the nodes and the determining of procedure's completion...
  18. ncbi Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer
    Grazia Artioli
    Medical Oncology Department, Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128 Padova, Italy
    Anticancer Res 30:3817-21. 2010
    ..This was a phase II study to assess the activity of a novel neoadjuvant regimen in locally-advanced breast cancer...
  19. ncbi Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin
    Domenico Rubello
    Nuclear Medicine Service, S Maria della Misericordia Rovigo Hospital, Rovigo, Italy
    Nucl Med Commun 25:1119-24. 2004
    ....
  20. ncbi Sentinel-node biopsy in breast cancer
    Gian Luca De Salvo
    N Engl J Med 349:1968-71; author reply 1968-71. 2003
  21. ncbi Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer
    Maria Ornella Nicoletto
    Medical Oncology Department, Istituto Oncologico Veneto, Padua, Italy
    Tumori 94:481-8. 2008
    ..To evaluate the accuracy of magnetic resonance imaging in assessing tumor response following neoadjuvant chemotherapy in patients with locally advanced breast cancer...